Edition:
United States

Surmodics Inc (SRDX.OQ)

SRDX.OQ on NASDAQ Stock Exchange Global Select Market

28.75USD
14 Dec 2017
Change (% chg)

-- (--)
Prev Close
$28.75
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
13,255
52-wk High
$34.15
52-wk Low
$22.50

Chart for

About

Surmodics, Inc. is a provider of medical device and in vitro diagnostic technologies to the healthcare industry. The Company operates through two segments: Medical Device and In Vitro Diagnostics. The Company's Medical Device segment consists of surface modification coating technologies to improve access, deliverability and... (more)

Overall

Beta: 0.87
Market Cap(Mil.): $385.10
Shares Outstanding(Mil.): 13.10
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 60.10 16.04
EPS (TTM): -- -- --
ROI: -- 13.32 34.69
ROE: -- 19.86 15.46

BRIEF-Surmodics Q4 gaap earnings per share $0.03

* Surmodics reports fourth quarter fiscal 2017 results and provides fiscal 2018 guidance

Nov 08 2017

BRIEF-Surmodics says received FDA 510(K) and CE mark clearance​

* Surmodics announces global approvals of .014" low-profile pta balloon dilation catheter

Sep 18 2017

BRIEF-Surmodics enters agreement with Baim Institute For Clinical Research​

* Says ‍on August 11 entered into a clinical trial services agreement with Baim Institute For Clinical Research, Inc - sec filing ​

Aug 15 2017

BRIEF-Surmodics Q3 non-GAAP earnings per share $0.09

* Surmodics reports third quarter fiscal 2017 results and updates fiscal 2017 guidance

Aug 03 2017

BRIEF-Surmodics receives IDE approval to initiate pivotal trial of the surveil™ drug-coated balloon

* Surmodics receives IDE approval to initiate pivotal trial of the surveil™ drug-coated balloon

Jul 26 2017

Competitors

Earnings vs. Estimates